Insider Trading Pulse — June 25, 2026

Activist investor Mantle Ridge LP sold 2.23M shares ($248M), reducing its stake to 10.48M shares, signaling potential lack of confidence in near-term turnaround strategy

COO sold $396K of shares under a 10b5-1 plan across 11 trades at $87.90-$91.69, indicating a planned diversification that may be neutral but the consistent selling is a cautionary signal

CMO Janku Filip sold 30,000 shares ($643K) after exercising options at $7.56, with 6 transactions reported, suggesting profit-taking as the stock trades near $21, which is 2.8x the exercise price

Director Deeter Byron B sold 8,845 shares ($577K) at $65.26, selling his entire stake post-IPO (down to 4,937 from zero after sale), a strong bearish signal from an early investor

President Debbi Nir sold 6,890 shares ($234K) under a 10b5-1 plan, a modest but consistent insider selling pattern to monitor

10% owner Saba Capital sold $1.71M worth, continuing its pattern of reducing exposure in closed-end funds, potentially signaling limited alpha in this strategy

Multiple directors and officers made small open-market purchases at $38.22 (totaling ~$900), alongside large equity awards, demonstrating insider alignment with shareholders despite minimal capital commitment

Two directors each bought 570 shares at $28.81 (~$16,400 combined), a positive open-market purchase signal from directors with small total holdings

10% owner Saba Capital Management bought 20,151 shares ($433K) at $21.31-$21.52, indicating bullish conviction on Mexican equities despite general CEF selling trends

CEO Wang Gaofei acquired 374,791 ADS, increasing his stake significantly; while the filing is neutral (likely a compensation/ownership reporting), the magnitude suggests insider alignment

President Bushway sold 10,000 shares ($516K), reducing his holdings by ~16%, a notable insider sell given the company's operational challenges and the executive's insider knowledge of supply chain trends

Four independent directors were each awarded 28,000 stock options at $4.08, making them aligned with shareholder value creation; the low strike price suggests management expects stock appreciation from current levels

Mantle Ridge's $248M sale (17.5% of its position sold) could indicate the activist is losing confidence in the turnaround, potentially leading to a stock decline of 10-15% if further selling occurs

CMO executed a net sale of $643K while options vesting suggests the stock at ~$21 is overvalued relative to internal expectations; biotech insiders often sell before negative catalysts

Director Deeter sold his entire direct stake immediately post-IPO lockup, a classic signal that the IPO price may have been too high or early investors see limited upside

COO sold shares weekly under 10b5-1 plan; while compliant, the total sale of $396K is material and could indicate lack of confidence in near-term growth trajectory

President sold 16% of holdings at $51.56; the food distribution sector faces margin pressure from inflation and labor costs, and this insider action suggests caution

Saba has sold $1.71M in the past month, potentially signaling they see better risk-adjusted returns elsewhere; closed-end funds trading at discounts remain risky if large holders exit

President sold shares for the second consecutive filing period; cross-border e-commerce faces currency headwinds and tariff risks that insiders may be pricing in

11 of 14 ORIX filings are equity compensation awards with minimal open-market purchases; while not bearish, it indicates limited cash-basis conviction from executives

Four executives were awarded 33-113 shares each, trivial amounts suggesting the equity incentive program is not materially motivating performance; low insider alignment

Three directors received 19,446 RSUs each; while alignment-boosting, the lack of insider open-market purchases alongside awards suggests a compensation-focused rather than conviction-based insider group

Saba Capital increased its stake by 20,151 shares, signaling a potential activist or value opportunity as the fund likely trades at a discount to NAV; Mexican equities could benefit from nearshoring trends

Two directors made open-market purchases at $28.81, the stock's current level; the BDC sector offers attractive yields, and insider buying at current prices suggests a dividend-validated floor

CEO Wang Gaofei acquired 374,791 ADS, a significant personal investment; Chinese ADR valuations remain depressed, and this insider action could precede a value unlock or buyback announcement

Four directors were awarded options at $4.08, implying management sees 50%+ upside; the oncology biotech has upcoming catalysts, and insider alignment is a positive signal

Multiple officers purchased shares in the open market at $38.22, a rare display of insider conviction; the diversified financial conglomerate's P/B is below 1x, and insider buying suggests management sees undervaluation

Director exercised 3,791 RSUs into common stock, increasing his direct holdings by 7.5x (from 500 to 4,291), a strong signal of confidence in the regional bank's recovery

Three directors received 19,446 RSUs each, tying their wealth to stock performance; the fintech is well-positioned for rate cuts and rising digital banking adoption, and insider alignment is a tailwind

COO exercised 80,427 ADS options at $3.76, holding all shares; the Chinese tea beverage company is growing rapidly, and executives retaining shares signals confidence in expansion strategy

While CMO sold $643K, he still holds 60,000 shares; if the stock dips on this news, it could be a buying opportunity for a biotech with promising oncology pipeline and upcoming data readouts

Director received 14,125 RSUs and 9,784 options, aligning with creation; the precision oncology diagnostics company is poised for growth as cancer screening adoption increases, and insider grants suggest board confidence

Mantle Ridge's $248M sale in Dollar Tree and Saba Capital's dual activity (selling BlackRock ESG Trust, buying Mexico Fund) highlights a divergence in activist conviction, with some reducing exposure while others accumulate value plays

Multiple biotech insiders (Monte Rosa CMO, Foghorn directors granted options) show a pattern of exercising low-cost options and selling shares, indicating that current valuations may be at a peak for some names; investors should scrutinize upcoming catalysts

CEOs and COOs of Chinese ADRs (Weibo, Chagee) are buying or exercising options, contrasting with US tech insider selling; this suggests overseas management teams see their stock as undervalued relative to growth prospects

Regional banks (MVB Financial, ORIX), BDCs (Sixth Street), and funds (Mexico Fund) show net insider buying or ownership increases, signaling that financial insiders see opportunity amid rate normalization and sector undervaluation

COOs and presidents at Sea Ltd, ServiceTitan, and Global-E Online are selling under 10b5-1 plans, a pattern that often precedes earnings misses or growth concerns; investors should monitor forward guidance for these names

Closed-end funds and REITs (UMH Properties) show multiple beneficial ownership reports with no material trades, suggesting that income-oriented stocks lack meaningful insider conviction — investors should focus on open-market purchases as a stronger signal

Mantle Ridge now holds 10.48M shares; watch for more 13D filings or public statements about the activist's strategy after this $248M sale

CMO still holds 60,000 shares; if further insider sales occur before key data readout, it may signal negative trial results; next earnings call date TBD

Director Deeter sold entire direct stake; monitor for other IPO lockup expirations and insider sales that could pressure the stock in coming weeks

COO selling under 10b5-1 plan until the plan expires; monitor quarterly earnings for guidance changes that may explain the diversification

President Debbi Nir continues selling; watch for insider purchases or forward guidance on cross-border e-commerce growth amid tariff uncertainty

Saba Capital now holds 2.26M shares; watch for activist proposals, tender offers, or further accumulation that could catalyze a discount-narrowing event

Multiple insider open-market purchases at $38.22; watch for additional buys or a buyback announcement as a signal of management's conviction in the stock's undervaluation

Multiple directors reported beneficial ownership but no trades; keep on watchlist for any insider purchases ahead of the REIT's earnings (scheduled Q2 report late July)